Abstract

Pharmacovigilance, the science and activities related to the detection, assessment, understanding, and prevention of adverse drug reactions (ADRs) and drug-related problems, is an essential component of clinical pharmacology. By systematically monitoring the safety of pharmaceuticals throughout their life cycle, pharmacovigilance ensures that the benefits of drugs outweigh their risks. This article explores the methodologies and practices employed in pharmacovigilance, reviews key findings regarding ADRs, and discusses their implications for patient safety and regulatory oversight. Through collaborative efforts among healthcare providers, regulatory authorities, and pharmaceutical industries, pharmacovigilance enhances the safety profile of medicines and promotes public health.